WELLS FARGO & COMPANY/MN
Position in RXRX — Recursion Pharmaceuticals, Inc.
CIK 72971
SAN FRANCISCO, CA
Position in RXRX
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$727,330
-$4,021,118 QoQ
Shares Held
236,916
-79.6% QoQ
Ownership
0.045%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in RXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WELLS FARGO & COMPANY/MN holds $1,292,861,286 across 390 Biotechnology names. RXRX ranks #112 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
744,995 | $332,670,066 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
342,763 | $113,409,991 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
142,021 | $109,731,102 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
1,535,737 | $99,254,679 | |
| 5 | INSM |
INSMED Inc
|
597,384 | $97,684,229 | |
| 6 | ASND |
Ascendis Pharma A/S
|
154,199 | $35,269,936 | |
| 7 | EXEL |
Exelixis, Inc.
|
687,304 | $29,478,466 | |
| 8 | ARGX |
Argenx SE
|
38,104 | $27,825,444 |
All Filings in RXRX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $727,330 | 236,916 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $4,748,448 | 1,160,990 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $3,910,660 | 801,365 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,098,186 | 217,033 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,193,719 | 603,728 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $3,098,249 | 458,321 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $757,961 | 115,017 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $579,112 | 77,215 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $583,413 | 58,517 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $512,423 | 51,970 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,873,361 | 244,884 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $846,140 | 113,272 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $591,148 | 88,628 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $15,612 | 2,025 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $18,343 | 1,724 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $11,281 | 1,386 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $71,914 | 10,044 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $867,548 | 50,645 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $299 | 13 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||